Gonadotropin-releasing hormone (GnRH) substances, a.k.a. puberty blockers, have been slapped with a warning label from the Food and Drug Administration.
And not without good reason as earlier this month after six minors (ages 5-12) experienced severe symptoms.
The minors, who were all biologically female, suffered from symptoms of “pseudotumor cerebri” (tumor-like masses in the brain), including visual disturbances (seeing bright lights that aren’t there), headache or vomiting, papilledema (swelling of the optic nerve), increased blood pressure, and abducens neuropathy (eye paralysis).
What is particularly surprising about the FDA’s announcement is because the medical establishment has suppressed information regarding the harmful effects of puberty blockers.
Last year, the American Academy of Pediatrics forbade the Society for Evidence-Based Gender Medicine from exhibiting at its annual conference, rejecting its application without explanation, while L’Oreal, the National Peanut Board, and Infinity Massage Chairs were accepted.
At the 2021 conference, 80% of American Academy of Pediatrics members supported a resolution calling for “more debate and discussion of the risks, benefits, and uncertainties inherent in the practice of medically transitioning minors,” but such discussion has not been forthcoming.
This year, the American Academy of Pediatrics “is suppressing support” for a similar resolution that calls for “rigorous systematic review of evidence and policy update for management of pediatric gender dysphoria,” according to Genspect, a group that supports “an evidence-based approach to gender distress.”
While the news from FDA is encouraging this isn’t the end of it.
In treating minors experiencing gender dysphoria, the medical side will change faster than the psychological side. The medical side deals with physical realities where solid data is difficult to ignore. The psychological side is far more abstract and has been more completely captured by the mistaken notions of identity that gave rise to the transgender movement.
So for Dr. Levine to stand there with a straight face telling the country that puberty blockers are life-saving medication, he is lying through his teeth.
As assistant secretary of health in the U.S. Department of Health and Human Services, Levine said last month, “Gender-affirming care is lifesaving, medically necessary, age-appropriate, and a critical tool for health care providers.”
Liar.